Literature DB >> 33381679

11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies.

James B Rowe1, John T O'Brien2, Nicolas Nicastro2,3, Negin Holland1, George Savulich2, Stephen F Carter2, Elijah Mak2, Young T Hong1,4, Selena Milicevic Sephton4, Tim D Fryer1,4, Franklin I Aigbirhio1,4.   

Abstract

OBJECTIVE: Dementia with Lewy bodies (DLB) is a common cause of dementia, but atrophy is mild compared to Alzheimer's disease. We propose that DLB is associated instead with severe synaptic loss, and we test this hypothesis in vivo using positron emission tomography (PET) imaging of 11C-UCB-J, a ligand for presynaptic vesicle protein 2A (SV2A), a vesicle membrane protein ubiquitously expressed in synapses.
METHODS: We performed 11C-UCB-J PET in two DLB patients (an amyloid-negative male and an amyloid-positive female in their 70s) and 10 similarly aged healthy controls. The DLB subjects also underwent PET imaging of amyloid (11C-PiB) and tau (18F-AV-1451). 11C-UCB-J binding was quantified using non-displaceable binding potential (BPND) determined from dynamic imaging. Changes in 11C-UCB-J binding were correlated with MRI regional brain volume, 11C-PiB uptake and 18F-AV-1451 binding.
RESULTS: Compared to controls, both patients had decreased 11C-UCB-J binding, especially in parietal and occipital regions (FDR-corrected p < 0.05). There were no significant correlations across regions between 11C-UCB-J binding and grey matter, tau (18F-AV1451) or amyloid (11C-PiB) in either patient.
CONCLUSIONS: Quantitative imaging of in vivo synaptic density in DLB is a promising approach to understanding the mechanisms of DLB, over and above changes in grey matter volume and concurrent amyloid/tau deposition. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41824-020-00093-9.
© The Author(s) 2020.

Entities:  

Keywords:  Amyloid; Brain atrophy; Dementia; Lewy bodies; Synaptic imaging; Tau

Year:  2020        PMID: 33381679      PMCID: PMC7752786          DOI: 10.1186/s41824-020-00093-9

Source DB:  PubMed          Journal:  Eur J Hybrid Imaging        ISSN: 2510-3636


  16 in total

1.  Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

Authors:  Yanjun Wu; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2002-12       Impact factor: 6.200

2.  Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.

Authors:  Michel Koole; June van Aalst; Martijn Devrome; Nathalie Mertens; Kim Serdons; Brigitte Lacroix; Joel Mercier; David Sciberras; Paul Maguire; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-18       Impact factor: 9.236

3.  In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease.

Authors:  Takuya Toyonaga; Levi M Smith; Sjoerd J Finnema; Jean-Dominique Gallezot; Mika Naganawa; Jason Bini; Tim Mulnix; Zhengxin Cai; Jim Ropchan; Yiyun Huang; Stephen M Strittmatter; Richard E Carson
Journal:  J Nucl Med       Date:  2019-05-17       Impact factor: 10.057

4.  Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.

Authors:  Ming-Kai Chen; Adam P Mecca; Mika Naganawa; Sjoerd J Finnema; Takuya Toyonaga; Shu-Fei Lin; Soheila Najafzadeh; Jim Ropchan; Yihuan Lu; Julia W McDonald; Hannah R Michalak; Nabeel B Nabulsi; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

Review 5.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

6.  Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies.

Authors:  Ninon Burgos; M Jorge Cardoso; Kris Thielemans; Marc Modat; Stefano Pedemonte; John Dickson; Anna Barnes; Rebekah Ahmed; Colin J Mahoney; Jonathan M Schott; John S Duncan; David Atkinson; Simon R Arridge; Brian F Hutton; Sebastien Ourselin
Journal:  IEEE Trans Med Imaging       Date:  2014-07-17       Impact factor: 10.048

7.  In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Nabeel B Nabulsi; Brent C Vander Wyk; Pradeep Varma; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Alzheimers Dement       Date:  2020-05-13       Impact factor: 21.566

8.  Synaptic Loss in Primary Tauopathies Revealed by [11 C]UCB-J Positron Emission Tomography.

Authors:  Negin Holland; P Simon Jones; George Savulich; Julie K Wiggins; Young T Hong; Tim D Fryer; Roido Manavaki; Selena Milicevic Sephton; Istvan Boros; Maura Malpetti; Frank H Hezemans; Franklin I Aigbirhio; Jonathan P Coles; John O'Brien; James B Rowe
Journal:  Mov Disord       Date:  2020-07-11       Impact factor: 9.698

9.  Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.

Authors:  David Matuskey; Sule Tinaz; Kyle C Wilcox; Mika Naganawa; Takuya Toyonaga; Mark Dias; Shannan Henry; Brian Pittman; Jim Ropchan; Nabeel Nabulsi; Ivonne Suridjan; Robert A Comley; Yiyun Huang; Sjoerd J Finnema; Richard E Carson
Journal:  Ann Neurol       Date:  2020-02-05       Impact factor: 10.422

10.  Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

Authors:  Erika Bereczki; Paul T Francis; David Howlett; Joana B Pereira; Kina Höglund; Anna Bogstedt; Angel Cedazo-Minguez; Jean-Ha Baek; Tibor Hortobágyi; Johannes Attems; Clive Ballard; Dag Aarsland
Journal:  Alzheimers Dement       Date:  2016-05-22       Impact factor: 21.566

View more
  4 in total

Review 1.  Fluid markers of synapse degeneration in synucleinopathies.

Authors:  Alba Cervantes González; Olivia Belbin
Journal:  J Neural Transm (Vienna)       Date:  2022-02-11       Impact factor: 3.575

Review 2.  Computational psychiatry: from synapses to sentience.

Authors:  Karl Friston
Journal:  Mol Psychiatry       Date:  2022-09-02       Impact factor: 13.437

Review 3.  Synaptic Vesicle Glycoprotein 2A: Features and Functions.

Authors:  Rachele Rossi; Shokouh Arjmand; Simone Larsen Bærentzen; Albert Gjedde; Anne M Landau
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 5.152

4.  Synaptic Loss in Multiple Sclerosis: A Systematic Review of Human Post-mortem Studies.

Authors:  E E Amelie Möck; Eveliina Honkonen; Laura Airas
Journal:  Front Neurol       Date:  2021-11-29       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.